Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Parambath AV"'
Autor:
Vats B; Biologics R&D, Viatris Pharmaceuticals Private Limited, Hyderabad, India., Goyal P; Biologics R&D, Viatris Inc, Canonsburg, PA, USA., Mathew Z; Quality Control Lab, Biocon Biologics India Limited, Bangalore, India., Ghosh R; Quality Control Lab, Biocon Biologics India Limited, Bangalore, India., Babu MN; Quality Control Lab, Biocon Biologics India Limited, Bangalore, India., Jadav RS; Quality Control Lab, Biocon Biologics India Limited, Bangalore, India., Nair AM; Quality Control Lab, Biocon Biologics India Limited, Bangalore, India., Subbarao M; Quality Control Lab, Biocon Biologics India Limited, Bangalore, India., Bera A; Quality Control Lab, Biocon Biologics India Limited, Bangalore, India., Prakash Sadasivappa K; Quality Control Lab, Biocon Biologics India Limited, Bangalore, India., Kabadi P; Quality Control Lab, Biocon Biologics India Limited, Bangalore, India., Sarkar A; Biologics R&D, Viatris Pharmaceuticals Private Limited, Hyderabad, India., Honnappa CG; Quality Control Lab, Biocon Biologics India Limited, Bangalore, India., Patnaik US; Biologics R&D, Viatris Pharmaceuticals Private Limited, Hyderabad, India., Singh A; Quality Control Lab, Biocon Biologics India Limited, Bangalore, India., Parambath AV; Quality Control Lab, Biocon Biologics India Limited, Bangalore, India., Ullanat R; Biologics R&D, Viatris Pharmaceuticals Private Limited, Hyderabad, India.
Publikováno v:
Expert opinion on biological therapy [Expert Opin Biol Ther] 2022 Feb; Vol. 22 (2), pp. 299-311. Date of Electronic Publication: 2021 May 02.